Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02198859 · ClinicalTrials.gov registry record · Phase 1
Evaluation of Lithium and It's Effect on Clinically Localized Prostate Cancer
A Phase 1 study, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 11
- Enrollment target
NCT02198859 is a Phase 1 study that has completed, run by University of Kansas Medical Center. The registered enrollment target is 11 participants.
The verdict
NCT02198859, a Phase 1 study, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 11 participants
- Enrollment target
Study Summary
Laboratory testing has suggested that lithium may decrease the incidence of certain types of cancer, including prostate cancer. Additional research has suggested that lithium decreases prostate cancer tumor size over time. This study will investigate the effect of lithium on men with prostate cancer.
Interventions
- DRUG Lithium Carbonate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2014-04 |
| Est. Completion | 2016-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02198859
The ClinicalTrials.gov registry entry for NCT02198859 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lithium Carbonate is the first listed.
NCT02198859 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02198859 about?
NCT02198859 is a clinical study titled "Evaluation of Lithium and It's Effect on Clinically Localized Prostate Cancer". Laboratory testing has suggested that lithium may decrease the incidence of certain types of cancer, including prostate cancer. Additional research has suggested that lithium decreases prostate cancer tumor size over time. This study will investigate the effect of lithium on men with prostate cancer...
What is the current status of trial NCT02198859?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 11 participants. The study started on 2014-04. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02198859?
The interventions under investigation include: Lithium Carbonate (DRUG).
Who is sponsoring clinical trial NCT02198859?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.